Company: STAA
Filing Date: 2025-12-11
Form Type: DFAN14A
Source: 0001213900-25-120777
Chunk: 13

Company: STAAR SURGICAL CO
Filing Date: 2025-12-11
Form: DFAN14A
Chunk 13
---
 against the Proposed Merger in September, peer multiples have expanded by a full turn , supporting a price for STAAR that is even higher than Alcon’s revised proposal Source: FactSet. 1. “Comparable MedTech Companies” include Alcon AG, Alphatec Holdings, Inc., AtriCure , Inc., Axogen , Inc., DexCom , Inc., Establishment Labs Holdings, Inc., Glaukos Corp, Insulet Corporation, iRhythm Technologies, Inc., Penumbra, Inc., PROCEPT BioRobotics Corp., TransMedics Group, Inc. Vericel Corporation and Treace Medical Concepts, Inc. Peer data refers to median. 2. Data as of September 23, 2025, the day before Broadwood filed its definitive proxy statement for the Special Meeting. 3. Data as of December 8, 2025, the day before Alcon announced that it had increased its proposed merger price. 4. Based on consensus estimates as of September 23, 2025 and STAAR’s cash and fully diluted shares outstanding and cash as of th e p eriod ended June 27, 2025. 1 Comparable MedTech Companies 1 Median EV/Revenue Multiple Implied Merger Price If STAAR’s Multiple Expanded In - Line w/ Peers 4 6.0x 4.9x 4.1x 6.9x 5.9x 5.0x CY 2025E CY 2026E CY2027E September 2025² December 2025³ +16% +21% +23% EV/Revenue Multiple of Initial Proposal 2 EV/Revenue Multiple +1 Full Turn $32.31 $32.34 $32.90 CY 2025E CY 2026E CY 2027E 5.1x 4.1x 3.8x 6.1x 5.1x 4.8x Revised Price Alcon’s bump was less than the price increase that STAAR could have achieved had it merely traded in - line with peers

Broadwood Partners, L.P. The Revised Merger Values STAAR Below Comparable MedTech Companies… 19 We believe STAAR warrants a materially higher valuation multiple, based on those of other comparable MedTech companies 1. Source: FactSet. Data as of December 8, 2025. 2. “Comparable MedTech Companies” include Alcon AG,